Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19854 studies found for:    "Vascular Diseases"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
22 Completed
Has Results
GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study
Condition: Peripheral Vascular Diseases
Interventions: Device: GORE VIABAHN Endoprosthesis;   Device: Bare Nitinol Stent
23 Completed
Has Results
Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab 0.5 or 0.3 mg/0.05 cc
24 Unknown  Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab 0.5 or 2.0 mg/0.05 cc
25 Unknown  Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab 2.0mg
26 Completed
Has Results
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
Condition: Cardiac Allograft Vasculopathy
Interventions: Drug: Pioglitazone;   Drug: Placebo
27 Unknown  Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
Condition: Peripheral Vascular Diseases
Intervention: Drug: adult stem cells
28 Completed Systematic Assessment of Vascular Risk
Condition: Peripheral Vascular Disease
Intervention:
29 Completed
Has Results
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: ramipril or placebo
30 Completed Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: fosbretabulin;   Drug: Saline
31 Completed
Has Results
Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)
Condition: Atherosclerotic Vascular Disease
Interventions: Drug: atorvastatin;   Drug: placebo
32 Completed Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab intravitreal injection
33 Completed
Has Results
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: Verteporfin Photodynamic Therapy;   Drug: Ranibizumab
34 Active, not recruiting A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
35 Not yet recruiting Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: Lucentis® (Raibizumab) double-dose;   Drug: Lucentis® (Raibizumab) regular-dose
36 Completed Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography
Condition: Cardiac Allograft Vasculopathy
Intervention:
37 Recruiting Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Interventions: Drug: Perflutren Lipid Microsphere;   Procedure: RTMPE
38 Completed Early Postoperative Fitting of the Air- Limb Prosthesis for Transtibial Amputees
Condition: Vascular Diseases
Intervention: Device: Air- Limb
39 Unknown  Identification of Non Invasive Biomarkers of Immune Endothelial Injury and Repair Associated With Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Biological: blood samples
40 Completed A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Condition: Idiopathic Polypoidal Choroidal Vasculopathy
Intervention: Drug: Zimura + Anti-VEGF

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.